⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Medical Robots Market worth $41.7 billion by 2031 | MarketsandMarkets™
prnewswire.com
ISRG
STRL
MDT
ZBH
ASNS
BDX
EKSO
JNJ
Collibra Named Databricks' Governance Partner of the Year; Collibra and Databricks Deepening a Partnership to Ground Agentic AI in Governed Context
prnewswire.com
RIVN
MA
BABA
UBER
CMG
ADI
AMZN
GOOG
MSFT
NVDA
CRM
PYPL
IBM
INTC
ADBE
NFLX
HON
GE
BA
CAT
UNH
PEP
KO
MCD
COST
WMT
TMO
ABBV
XOM
CVX
JPM
BAC
WFC
C
GS
MS
DIS
CMCSA
VZ
T
SBUX
NKE
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
PG
LMT
RTX
GD
LRCX
MU
AMD
QCOM
TXN
AVGO
AMAT
KLAC
ASML
ENPH
CRSP
REGN
VRTX
BIIB
AZN
SNY
LLY
BNTX
XCUR
ALGN
TDOC
ZBRA
ROKU
UL
Process Industries Converge in Houston for Inaugural ChemE Show 2026 Powered by ACHEMA
prnewswire.com
XOM
JNJ
LLY
LIN
FRO
APD
ETR
AA
PH
Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida
businesswire.com
JNJ
EcoVadis Joins European Commission's AI Act Advisory Forum to Shape Future of Responsible AI
prnewswire.com
JNJ
UL
JPM
Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day
globenewswire.com
JNJ
ABT
New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma
globenewswire.com
JNJ
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma
prnewswire.com
JNJ
Patient Monitoring Devices Market worth $76.11 billion by 2031 | MarketsandMarkets™
prnewswire.com
MDT
ABT
DXCM
GEHC
BSX
MASI
BIIB
AMGN
GILD
BMY
MRK
PFE
JNJ
BAX
BOSC
Wayrilz (rilzabrutinib, Sanofi) Positioned to Define Third-Line Treatment in Warm Autoimmune Hemolytic Anemia (w-AIHA) as IMAAVY (niopcalimab, Jonhson & Johnson) Follows Closely with Positive Data Announcement at EHA 2026
globenewswire.com
SNY
JNJ